510(k) K133637
K133637 is an FDA 510(k) premarket notification submitted by Alere Scarborough, Inc D/B/A Binax, Inc. for the device "ALERE INFLUENZA A & B TEST". The FDA issued a decision of Substantially Equivalent on December 18, 2013. The device falls under product code PSZ (Devices Detecting Influenza A, B, And C Virus Antigens), a Class II device regulated under 21 CFR 866.3328. Alere Scarborough, Inc D/B/A Binax, Inc. has at least 3 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- December 18, 2013
- Date Received
- November 7, 2013
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Devices Detecting Influenza A, B, And C Virus Antigens
- Device Class
- Class II
- Regulation Number
- 866.3328
- Review Panel
- MI
- Submission Type
An influenza virus antigen detection test system is a device intended for the qualitative detection of influenza viral antigens directly from clinical specimens in patients with signs and symptoms of respiratory infection.